Visiongain Publishes HIV and HBV Therapies Market Report 2022-2032
The global HIV and HBV Therapies market is estimated to be valued at US$36.2 billion in 2022 and is projected to grow at a CAGR of 6.5% during the forecast period 2022-2032.
Visiongain Publishes Vehicle to Grid (V2G) Market Report 2023-2033
The global vehicle to grid (V2G) market was valued at US$1,014 million in 2022 and is projected to grow at a CAGR of 21.5% during the forecast period 2023-2033.
Visiongain Publishes Edge Computing Market Report 2023-2033
The global edge computing market was valued at US$39,887 million in 2022 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.
Visiongain Publishes Post-Consumer Recycled Plastic Market Report 2023-2033
The global post-consumer recycled plastic market was valued at US$16,239 million in 2022 and is projected to grow at a CAGR of 9.4% during the forecast period 2023-2033.
Visiongain Publishes CAR-T Therapy Market Report 2022-2032
The CAR-T Therapy market was valued at US$1.9 billion in 2021 and is projected to grow at a CAGR of 42.95% during the forecast period 2022-2032.
Visiongain Publishes Pharma Contract Sales Market Report 2022-2032
The global pharma contract sales market was valued at US$5,303.0 million in 2021 and is projected to grow at a CAGR of 5.8% during the forecast period 2022-2032.
Visiongain Publishes RNA Based Therapeutics and Vaccines Market Report 2022-2032
The RNA therapeutics market was valued at US$5,876.7 million in 2021 and is projected to grow at a CAGR of 18.68% during the forecast period 2022-2032.
Visiongain Publishes Antisense Oligonucleotide (ASO) Therapeutics Market Report 2022-2032
The antisense oligonucleotide therapeutics market was valued at US$17.46 billion in 2021 and is projected to grow at a CAGR of 13.71% during the forecast period 2022-2032.
Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2022-2032
The viral vectors and plasmid DNA manufacturing market was valued at US$482.3 million in 2021 and is projected to grow at a CAGR of 18.09% during the forecast period 2022-2032.
Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2022-2032
The OTC drugs & dietary supplements market was valued at US$211.75 billion in 2021 and is projected to grow at a CAGR of 7.90% during the forecast period 2022-2032.
Visiongain Publishes Air Traffic Management Market Report 2022-2032
The air traffic management market was valued at US$9.68 billion in 2021 and is projected to grow at a CAGR of 11.02% during the forecast period 2022-2032.
Visiongain Publishes Auto Electrification Market Report 2022-2032
The auto electrification market was valued at US$82.7 billion in 2021 and is projected to grow at a CAGR of 10.30% during the forecast period 2022-2032.
Visiongain Publishes Microelectronics Semiconductor Packaging (MIPAC) Market Report 2022-2032
The global microelectronics semiconductor packaging (MIPAC) market was valued at US$44,187 million in 2021 and is projected to grow at a CAGR of 4.6% during the forecast period 2022-2032.
Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032
The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.
Visiongain Publishes Battery Electric Vehicle (BEV) Market Report 2022-2032
The global battery electric vehicle (BEV) market was valued at US$66,867 million in 2021 and is projected to grow at a CAGR of 18.6% during the forecast period 2022-2032.
Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032
The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.
Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032
The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.
Visiongain Publishes Aerial Geophysical Services Market Report 2022-2032
The global aerial geophysical service market was valued at US$4,741 million in 2021 and is projected to grow at a CAGR of 4.6% during the forecast period 2022-2032.
Visiongain Publishes Gene Therapy R&D Market Report 2022-2032
The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.
Visiongain Publishes Floating Liquefied Natural Gas (FLNG) Market Report 2022-2032
The global floating liquefied natural gas (FLNG) market was valued at US$16,670 million in 2021 and is projected to grow at a CAGR of 20.1% during the forecast period 2022-2032.
